Choo Chee Kong
- SEC CIK
- 0001970632
In the past year, 2 open-market purchase filings worth $428.8K and no sales.
Current role at each company
- GDTC CytoMed Therapeutics LtdDirector, 10% Owneras of Jul 24, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $428.8K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$428.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Choo Chee Kong as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 24, 2026 (view filing)9:01 PM ET | Jul 14-20 | 10 days | Choo Chee KongDirector, 10% Owner | PPurchaseORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED | +200.0K | $1.50 | +$300.0K | +46.5%630.3K after | Amended2 lots |
| Jun 15, 2026 (view filing) | May 13 | 33 daysLate | Choo Chee KongDirector, 10% Owner | PPurchaseOrdinary Shares, no par value per share | +112.0K | $1.15 | +$128.8K | +35.2%430.3K after |